Benazzi Franco
Hecker Psychiatry Research Center, Forli, Italy.
World J Biol Psychiatry. 2007;8(2):105-11. doi: 10.1080/15622970601042500.
The current categorical splitting of bipolar and depressive disorders has been questioned. Age at onset is an important variable used to support such a division. Study aim was to assess the distribution of age at onset between bipolar II disorder (BP-II) and major depressive disorder (MDD), and onset age-bipolar family history, onset age-BP-II diagnosis dose-response relationships. No bi-modal distribution and no presence of dose-response relationships would not support a categorical distinction between BP-II and MDD. Consecutive 389 BP-II and 261 MDD major depressive episode (MDE) outpatients were interviewed with the DSM-IV Structured Clinical Interview and the Family History Screen, by a mood specialist psychiatrist in a private practice. Age at onset was defined as age at onset of the first MDE. Distribution of age at onset between BP-II and MDD was studied by Kernel density estimate and histogram methods, dose-response relationships by ROC analysis. BP-II, versus MDD, had significantly lower age at onset, more recurrences, and more bipolar family history. Kernel density estimate and histogram distributions of age at onset showed no bi-modality. Likelihood ratios between age at onset and bipolar family history loading, and between age at onset and BP-II diagnosis, showed dose-response relationships. The bi-modality and dose-response approaches, versus classic diagnostic validators, seem to support a dimensional relationship between BP-II and MDD.
双相情感障碍和抑郁症目前的分类划分受到了质疑。发病年龄是用于支持这种划分的一个重要变量。研究目的是评估双相II型障碍(BP-II)和重度抑郁症(MDD)之间的发病年龄分布,以及发病年龄与双相情感障碍家族史、发病年龄与BP-II诊断的剂量反应关系。不存在双峰分布且不存在剂量反应关系将不支持BP-II和MDD之间的分类区别。由一名私人执业的情绪专科精神科医生,使用《精神疾病诊断与统计手册》第四版结构化临床访谈和家族史筛查,对389例BP-II和261例MDD重度抑郁发作(MDE)门诊患者进行了连续访谈。发病年龄定义为首次MDE的发病年龄。通过核密度估计和直方图方法研究BP-II和MDD之间的发病年龄分布,通过ROC分析研究剂量反应关系。与MDD相比,BP-II的发病年龄显著更低,复发次数更多,双相情感障碍家族史更多。发病年龄的核密度估计和直方图分布未显示双峰性。发病年龄与双相情感障碍家族史负荷之间以及发病年龄与BP-II诊断之间的似然比显示出剂量反应关系。与经典诊断验证方法相比,双峰性和剂量反应方法似乎支持BP-II和MDD之间的维度关系。